ASC-J9|ASCJ9|supplier DC Chemicals

Cas No.:	917813-54-8
Synonyms:	ASC J9
SMILES:	O=C(/C=C(O)/C=C/C1=CC(OC)=C(OC)C=C1)/C=C/C(C=C2OC)=CC=C2OC
Formula:	C₂₃H₂₄O₆
M.Wt:	396.43
Purity:	99%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:

For the detailed information about the solubility of ASC-J9 in water, the solubility of ASC-J9 in DMSO, the solubility of ASC-J9 in PBS buffer, the animal experiment（test） of ASC-J9, the in vivo,in vitro and clinical trial test of ASC-J9, the cell experiment（test） of ASC-J9, the IC50, EC50 and Affinity of ASC-J9 , please contact DC Chemicals.

MSDS

COA

LOT NO.	DOWNLOAD

2018-0101

Cat. No.	Product name	Field of application
DC47757	A4B17	A4B17 is an androgen receptor N-terminal inhibitor for treating androgen-responsive prostate cancer.
DC47094	MK-3984	MK-3984 is a selective androgen receptor modulator (SARM). MK-3984 can be used for the research of muscle wasting associated with cancer.
DC47001	Rezvilutamide	Rezvilutamide (SHR3680) is an androgen receptor antagonist. Rezvilutamide (SHR3680) is used for the study of prostate cancer.
DC46941	Cl-4AS-1	Cl-4AS-1, a potent steroidal androgen receptor (AR) agonist (IC50 = 12 nM), is also an inhibitor of 5α-reductase types I and II (IC50 = 6 and 10 nM, respectively).
DC45884	Honokiol DCA	Honokiol DCA (Honokiol dichloroacetate) is a dichloroacetate analog of Honokiol. Honokiol DCA can inhibit the growth of human prostate cancer cells in vitro and suppress the androgen receptor (AR) protein level.
DC45606	CLP-3094	CLP-3094 is a potent BF3 (binding function 3)-directed inhibitor of the androgen receptor (AR). CLP-3094 inhibits AR transcriptional activity (IC50=4 μM). CLP-3094 is a selective, potent GPR142 antagonist.
DC41259	Bromopropylate	Bromopropylate is a pesticide with moderate anti-androgenic activities.
DC41093	Apalutamide D4	Apalutamide D4 (ARN-509 D4) is a deuterium labeled Apalutamide. Apalutamide is a potent and competitive androgen receptor (AR) antagonist, binding AR with an IC50 of 16 nM.
DC40448	Androgen receptor antagonist 1	Androgen receptor antagonist 1 is an orally available full androgen receptor (AR) antagonist with an IC50 of 59 nM. Androgen receptor antagonist 1 (Compound 6) can be used in the synthesis of PROTAC AR degraders, which results 24% and 47 % AR protein degradation in LNCaP cells at 1 μM and 10 μM, respectively.
DC40171	(R)-UT-155	(R)-UT-155 (compound 11) is a selective androgen receptor degrader (SARD) ligand. Less active than the S-isomer.